ALLMedicine™ Hypocitraturia Center
Research & Reviews 129 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596945
BMC Urology; Taguchi K, Hamamoto S et. al.
Oct 30th, 2020 - Patients with urolithiasis have a lower bone mineral density (BMD) than those without stones, suggesting a potential correlation between calcium stone formation and bone resorption disorders, including osteopenia and osteoporosis. To investigate t...
https://doi.org/10.1007/s00345-020-03449-9
World Journal of Urology; Zhao Y, Fang X et. al.
Sep 16th, 2020 - To investigate the prevalence of inherited causes in an early onset urolithiasis cohort and each metabolic subgroup. A retrospective analysis of both metabolic and genomic data was performed for the first 105 pediatric urolithiasis patients who un...
https://doi.org/10.1080/14656566.2019.1685979
Expert Opinion on Pharmacotherapy; Abou Chakra M, Dellis AE et. al.
Nov 12th, 2019 - Introduction: Urolithiasis is a common, highly recurrent disease with increasing prevalence worldwide. There are many dietary and pharmacological measures to prevent kidney stones.Areas covered: Herein, the authors explore medical expulsive therap...
https://emedicine.medscape.com/article/444968-overview
Jul 23rd, 2019 - Practice Essentials Hypocitraturia, a low amount of citrate in the urine, is an important risk factor for kidney stone formation. Citrate in the urine has long been recognized as an inhibitor of calcium salt crystallization. Citrate is the dissoci...
https://emedicine.medscape.com/article/444968-print
Jul 23rd, 2019 - Hypocitraturia, a low amount of citrate in the urine, is an important risk factor for kidney stone formation. Citrate in the urine has long been recognized as an inhibitor of calcium salt crystallization. Citrate is the dissociated anion of citric...
Clinicaltrials.gov 135 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596945
BMC Urology; Taguchi K, Hamamoto S et. al.
Oct 30th, 2020 - Patients with urolithiasis have a lower bone mineral density (BMD) than those without stones, suggesting a potential correlation between calcium stone formation and bone resorption disorders, including osteopenia and osteoporosis. To investigate t...
https://doi.org/10.1007/s00345-020-03449-9
World Journal of Urology; Zhao Y, Fang X et. al.
Sep 16th, 2020 - To investigate the prevalence of inherited causes in an early onset urolithiasis cohort and each metabolic subgroup. A retrospective analysis of both metabolic and genomic data was performed for the first 105 pediatric urolithiasis patients who un...
https://doi.org/10.1080/14656566.2019.1685979
Expert Opinion on Pharmacotherapy; Abou Chakra M, Dellis AE et. al.
Nov 12th, 2019 - Introduction: Urolithiasis is a common, highly recurrent disease with increasing prevalence worldwide. There are many dietary and pharmacological measures to prevent kidney stones.Areas covered: Herein, the authors explore medical expulsive therap...
https://emedicine.medscape.com/article/444968-overview
Jul 23rd, 2019 - Practice Essentials Hypocitraturia, a low amount of citrate in the urine, is an important risk factor for kidney stone formation. Citrate in the urine has long been recognized as an inhibitor of calcium salt crystallization. Citrate is the dissoci...
https://emedicine.medscape.com/article/444968-print
Jul 23rd, 2019 - Hypocitraturia, a low amount of citrate in the urine, is an important risk factor for kidney stone formation. Citrate in the urine has long been recognized as an inhibitor of calcium salt crystallization. Citrate is the dissociated anion of citric...
News 4 results
https://www.medscape.com/viewarticle/536604_2
Jul 12th, 2006 - Introduction Citrate inhibits renal stone recurrence by preventing crystal growth, aggregation, and nucleation. It is a strong chelator of calcium and one of the most common therapeutic agents used to prevent calcium oxalate, uric acid, or cystine...
https://www.medscape.com/viewarticle/536604
Jul 12th, 2006 - Abstract Citrate supplementation is widely used in the prevention of recurrent nephrolithiasis with hypocitraturia. Potassium citrate is the most commonly used citrate agent for this indication. In patients with chronic diarrheal syndromes, the ab...
https://www.medpagetoday.com/primarycare/dietnutrition/3411
May 25th, 2006 - Action Points Explain to kidney stone patients being treated with potassium citrate that this study suggests they might benefit from the extra fluid provided by lemonade as well as an increase in urinary citrate excretion. Remind patients that lem...